Catalog No.
DHB99201
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Mouse
Isotype
IgG1-kappa
Clonality
Monoclonal
Applications
Research Grade Biosimilar
Target
FGB, Fibrinogen beta chain
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P02675
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
Indium (111In) biciromab, T2G1, CAS: 138783-13-8
Clone ID
Biciromab
Note
For research use only. Not suitable for clinical or therapeutic use.
Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging, PMID: 1645666
Thallium and indium antimyosin dual-isotope single-photon emission tomography in acute myocardial infarction to identify patients at further ischaemic risk, PMID: 8062846
Focal myocardial injury following blunt chest trauma: a comparison of indium-111 antimyosin scintigraphy with other noninvasive methods, PMID: 1575135
Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging, PMID: 2156026
Myocardial indium-111-antimyosin uptake in essential hypertension, PMID: 12802472
Myocardial uptake of indium-111 antimyosin after coronary angioplasty. Relationship with the total burden of ischaemia, PMID: 7671892
Prognosis after acute myocardial infarction, PMID: 7726939
Pulmonary uptake in indium-111-antimyosin Fab fragment imaging following human cardiac transplantation, PMID: 8294997
Infarcted heart uptake and biodistribution of radiolabelled anti-myosin monoclonal antibody in rat and dog myocardial infarct models, PMID: 2254094
Biodistribution, radiation dosimetry and pharmacokinetics of 111In-antimyosin in idiopathic inflammatory myopathies, PMID: 10086712
[111In-antimyosin Fab myocardial scintigraphy], PMID: 2002591
Persistent uptake of indium-111-antimyosin monoclonal antibody in patients with myocardial infarction, PMID: 2239654
Guides to surgical intervention in chronic aortic regurgitation: myocytes file a claim, PMID: 9138843
Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection, PMID: 1846889
Antimyosin positivity in doxorubicin cardiotoxicity: earlier than the conventional evidence, PMID: 8355071
Transmural uptake of perfusion tracers and infarct-specific tracers, PMID: 1531071
Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies, PMID: 8181129
Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis, PMID: 9374348
Optimizing antibodies for use in nuclear medicine, PMID: 1880578
Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies, PMID: 8996309
Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging, PMID: 9581733
Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts, PMID: 1884451
Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake, PMID: 11168306
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms, PMID: 11693753
Natural evolution of antimyosin scan and cardiac function in patients with acute myocarditis, PMID: 8707437
Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies, PMID: 8355070
Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy, PMID: 11911911
Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers, PMID: 1880577
Myocardial cell damage in human hypertension, PMID: 11127461
Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer, PMID: 2266394
[Indium III monoclonal antimyosin antibody scintigraphy for the detection of chronic myocardial infarction apart from the acute phase], PMID: 8729367
Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity, PMID: 7472595
Detection of myocardial necrosis and inflammation by nuclear cardiac imaging, PMID: 8033178
[Image diagnosis of heart diseases using new radioisotope compounds], PMID: 8537769
[Evaluation of myocardial perfusion and injured myocardium by scintigraphy], PMID: 9097695
Technetium 99m glucarate: what will be its clinical role?, PMID: 9278881
Antimyosin antibody imaging in experimental aortic regurgitation, PMID: 9138836
Myocardial uptake of 99mTc-annexin-V and 111In-antimyosin-antibodies after ischemia-reperfusion in rats, PMID: 17805532
Nuclear cardiology: myocardial perfusion and function, PMID: 1888653
Detection of acute myocardial infarcts by infarct-avid imaging, PMID: 1846912
Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?, PMID: 2266395
Is cyclosporine toxic to the heart?, PMID: 8476891
Of antimyosin imaging and histopathology of myocardial infarction: when, where, and why, PMID: 2022997
Immunoscintigraphy with 111In antimyosin Fab, PMID: 2277688
Leiomyosarcoma of the transverse colon. Report of a case with discussion, PMID: 2182312
Clinical role of indium-111 antimyosin imaging, PMID: 1752262
Assessment of acute myocardial infarction by nuclear imaging techniques, PMID: 1387514
Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity, PMID: 21421717
Molecular imaging of cell death, PMID: 19362149
Myocardial infarction imaging, PMID: 2694035
For research use only. Not for human or drug use.
